Summary

＜P>The veterinary reference laboratory market is forecasted to grow from USD 4.75 million in 2025 to USD 6.46 million by 2030, recording a CAGR of 6.3%. The increasing prevalence of zoonotic and chronic animal diseases, rising companion animal ownership, and the growing emphasis on preventive healthcare primarily drive market expansion. The rising demand for advanced diagnostic testing, including molecular diagnostics, immunodiagnostics, and clinical chemistry, has accelerated the establishment of high-throughput reference laboratories in both developed and emerging regions. Moreover, technological advancements in automation, AI-based image analysis, and molecular testing are enabling faster turnaround times and improved diagnostic accuracy, fostering greater trust among veterinarians and pet owners.

https://mnmimg.marketsandmarkets.com/Images/veterinary-reference-laboratory-market-img-overview.webp

At the same time, the increasing integration of diagnostic services with digital platforms and laboratory information management systems (LIMS) is streamlining workflows, enhancing sample traceability, and enabling remote access to test results. The rising focus on early disease detection and companion animal wellness programs further supports test adoption, while expanding veterinary corporatization and partnerships between clinics and reference labs are driving consistent sample inflows. However, the market faces challenges such as high operational and testing costs, a shortage of skilled laboratory professionals, and stringent regulatory standards governing veterinary diagnostics. Additionally, maintaining quality assurance across diverse geographies and addressing biosecurity and sample transport challenges remain key priorities for laboratories aiming to sustain accuracy, reliability, and growth momentum.

The clinical pathology segment accounted for the largest share of the market, by application, in 2024.
Based on application, the veterinary reference laboratory market is segmented into clinical pathology, bacteriology, virology, parasitology, and other applications. In 2024, clinical pathology accounted for the largest share of the market. This dominance is attributed to the segment’s critical role in delivering detailed diagnostic insights through hematology, cytology, and clinical chemistry testing. These analyses enable veterinarians to accurately diagnose systemic disorders, track therapeutic progress, and effectively manage complex disease conditions. The rising companion animal population and increasing frequency of veterinary consultations have fueled the demand for routine pathology services. Moreover, technological advancements in automated analyzers and digital pathology systems have significantly improved diagnostic precision, efficiency, and turnaround time, further driving market growth in this segment.

The veterinary clinics & hospitals segment is expected to dominate the market, by end user, during the forecast period.
Based on end user, the veterinary reference laboratory market is segmented into veterinary clinics and hospitals, research institutes and universities, point-of-care/in-house labs, and other end users. In 2024, veterinary clinics and hospitals accounted for the largest share of the global market. This dominance is primarily driven by the rising volume of diagnostic testing conducted through referral partnerships with centralized laboratories, as clinics increasingly outsource advanced and specialized tests such as molecular diagnostics, immunodiagnostics, and clinical chemistry to improve diagnostic accuracy and efficiency.
The growing companion animal population, higher pet healthcare expenditure, and expanding network of small and large veterinary practices have further contributed to the rising sample inflow from clinics and hospitals. These facilities rely on reference laboratories for confirmatory and complex testing that cannot be efficiently performed in-house, thereby enhancing treatment outcomes and operational workflows. Additionally, the integration of digital sample management systems and automated result reporting between clinics and reference labs is improving turnaround times and supporting evidence-based veterinary care.


In 2024, North America dominated the veterinary reference laboratory market.
The veterinary reference laboratory market is segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. In 2024, North America accounted for the largest share of the global market. This dominance can be attributed to several key factors, including the high prevalence of companion animal ownership, strong awareness of preventive veterinary care, and significant healthcare expenditure on pets across the region. The presence of leading industry players such as IDEXX Laboratories, Zoetis Services LLC, and Mars, Incorporated, coupled with a well-established network of veterinary hospitals and diagnostic centers, has further reinforced the region’s leadership. Within North America, the United States held the largest market share, supported by the country’s advanced veterinary infrastructure, growing demand for specialized and molecular diagnostic testing, and rapid adoption of automation and digital pathology solutions. Additionally, the U.S. market benefits from favorable pet insurance penetration, a robust ecosystem of veterinary service providers, and strong investment in R&D for companion and livestock diagnostic innovations.

Breakdown of supply-side primary interviews:
? By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
? By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
? By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Breakdown of demand-side primary interviews:
? By Company Type: Veterinary Clinics & Hospitals (70%), POC/In-house labs (15%), Research Institutions and Universities (10%), and Other End Users (5%)
? By Designation: Veterinary Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
? By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)

Research Coverage
This report studies the veterinary reference laboratory market based on service, application, animal type, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market's opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.
Reasons to Buy the Report
The report can help established companies and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.

This report provides insights into the following points:
? Analysis of key drivers, opportunities, restraints, and challenges influencing the growth of the veterinary reference laboratory market.
? Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and service launches in the veterinary reference laboratory market
? Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of veterinary reference laboratory services across regions.
? Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary reference laboratory market.
? Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary reference laboratory market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 48
1.1 STUDY OBJECTIVES 48
1.2 MARKET DEFINITION 48
1.3 STUDY SCOPE 48
1.3.1 MARKET SEGMENTATION 49
1.3.2 REGIONAL SCOPE 50
1.3.3 INCLUSIONS & EXCLUSIONS 50
1.3.4 YEARS CONSIDERED 51
1.4 MARKET STAKEHOLDERS 51
1.5 SUMMARY OF CHANGES 52
2 RESEARCH METHODOLOGY 54
2.1 RESEARCH DATA 54
2.2 RESEARCH METHODOLOGY DESIGN 54
2.2.1 SECONDARY DATA 55
2.2.1.1 Key sources of secondary research 55
2.2.1.2 Key objectives of secondary research 56
2.2.1.3 Key data from secondary sources 57
2.2.2 PRIMARY DATA 57
2.2.2.1 Key primary sources 58
2.2.2.2 Key objectives of primary research 58
2.2.2.3 Key data from primary sources 59
2.2.2.4 Key industry insights 60
2.3 MARKET SIZE ESTIMATION 62
2.3.1 REVENUE SHARE ANALYSIS 62
2.3.2 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 64
2.3.3 DEMAND-SIDE ANALYSIS 64
2.3.4 TOP-DOWN APPROACH 65
2.3.5 BOTTOM-UP APPROACH 66
2.4 DATA TRIANGULATION 68
2.5 MARKET SHARE ANALYSIS 69
2.6 STUDY ASSUMPTIONS 70
2.6.1 MARKET ASSUMPTIONS 70
2.6.2 GROWTH RATE ASSUMPTIONS 70
2.7 RISK ANALYSIS 71
2.8 RESEARCH LIMITATIONS 71
2.8.1 METHODOLOGY-RELATED LIMITATIONS 71
2.8.2 SCOPE-RELATED LIMITATIONS 71
3 EXECUTIVE SUMMARY 72
4 PREMIUM INSIGHTS 78
4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW 78
4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET,
BY PRODUCT AND COUNTRY (2024) 79
4.3 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX 80
4.4 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80
4.5 VETERINARY REFERENCE LABORATORY MARKET: DEVELOPED VS.
EMERGING ECONOMIES 81
5 MARKET OVERVIEW 82
5.1 MARKET DYNAMICS 83
5.1.1 DRIVERS 83
5.1.1.1 Growing routine wellness and oncology screening in
companion animals 83
5.1.1.2 Rapid adoption of digital pathology and telepathology 84
5.1.1.3 Increasing prevalence/awareness of zoonotic and emerging diseases 85
5.1.1.4 Growth in companion animal population 87
5.1.1.5 Rising demand for animal-derived food products 90
5.1.1.6 Increasing demand for pet insurance and growing animal
health expenditure 90
5.1.2 RESTRAINTS 92
5.1.2.1 Competition from in-clinic and point-of-care testing 92
5.1.2.2 High capital investment and fixed cost burden in veterinary reference laboratories 92
5.1.3 OPPORTUNITIES 93
5.1.3.1 Potential growth opportunities in emerging economies 93
5.1.3.2 Investment in advanced technologies in veterinary reference laboratories 94
5.1.4 CHALLENGES 95
5.1.4.1 Competitive pressure and margin pressure in veterinary reference laboratories 95
5.1.4.2 Data privacy, biosecurity, and sample ownership in veterinary reference laboratories 95
5.2 INDUSTRY TRENDS 96
5.2.1 DIGITAL PATHOLOGY, TELECYTOLOGY, AND AI FROM PILOT TO COMMERCIAL SERVICES 96
5.2.2 CONTINUED CONSOLIDATION AND VERTICAL INTEGRATION ACROSS ANIMAL-HEALTH ECOSYSTEM 97
5.3 TECHNOLOGY ANALYSIS 97
5.3.1 KEY TECHNOLOGIES 97
5.3.1.1 Real-time PCR/Quantitative PCR (qPCR) and digital PCR (dPCR) 97
5.3.1.2 Next-generation/Metagenomic sequencing (NGS/mNGS) 98
5.3.1.3 CRISPR-based diagnostics 99
5.3.2 ADJACENT TECHNOLOGIES 99
5.3.2.1 Integrated LIMS and one health surveillance platforms 99
5.3.2.2 AI-driven diagnostic tools 100
5.3.3 COMPLEMENTARY TECHNOLOGIES 100
5.3.3.1 Telepathology 100
5.3.3.2 Breath and saliva-based diagnostic tools 101
5.4 PORTER’S FIVE FORCES ANALYSIS 102
5.4.1 THREAT OF NEW ENTRANTS 103
5.4.2 THREAT OF SUBSTITUTES 103
5.4.3 BARGAINING POWER OF SUPPLIERS 103
5.4.4 BARGAINING POWER OF BUYERS 104
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 104
5.5 KEY STAKEHOLDERS & BUYING CRITERIA 105
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 105
5.5.2 KEY BUYING CRITERIA 106
5.6 REGULATORY ANALYSIS 107
5.6.1 REGULATORY LANDSCAPE 107
5.6.1.1 North America 107
5.6.1.1.1 US 107
5.6.1.2 Europe 108
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
5.7 PATENT ANALYSIS 111
5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORY 111
5.7.2 JURISDICTION & TOP APPLICANT ANALYSIS 112
5.7.3 MAJOR PATENTS 113
5.8 PRICING ANALYSIS 115
5.8.1 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022?2024 115
5.8.2 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY AND IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022?2024 117
5.9 REIMBURSEMENT ANALYSIS 119
5.10 PET PARENT BEHAVIOUR 120
5.11 KEY CONFERENCES & EVENTS, 2025?2026 122
5.12 END-USER PERSPECTIVE & UNMET NEEDS 123
5.13 IMPACT OF AI/GEN AI ON VETERINARY REFERENCE LABORATORY MARKET 124
5.13.1 INTRODUCTION 124
5.13.2 MARKET POTENTIAL IN VETERINARY REFERENCE LABORATORY ECOSYSTEM 124
5.13.3 AI-USE CASES 125
5.13.4 KEY COMPANIES IMPLEMENTING AI 125
5.14 ECOSYSTEM MAP 126
5.15 ROLE IN ECOSYSTEM 127
5.16 VALUE CHAIN ANALYSIS 128
5.17 INVESTMENT & FUNDING SCENARIO 130
5.18 CASE STUDY ANALYSIS 131
5.18.1 DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES 131
5.18.2 IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING 132
5.18.3 VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW 133
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 134
5.20 IMPACT OF 2025 US TARIFF ON VETERINARY REFERENCE LABORATORY MARKET 134
5.20.1 INTRODUCTION 134
5.20.2 KEY TARIFF RATES 136
5.20.3 PRICE IMPACT ANALYSIS 137
5.20.4 IMPACT ON COUNTRY/REGION 138
5.20.4.1 North America 138
5.20.4.2 Europe 138
5.20.4.3 Asia Pacific 139
5.20.4.4 Latin America 139
5.20.5 IMPACT ON END-USE INDUSTRIES 139
5.20.5.1 Veterinary hospitals & clinics 139
5.20.5.2 Point-of-care (POC) and in-house testing setups 140
5.20.5.3 Veterinary research institutes & universities 140
5.20.5.4 Other end users 140
6 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE 141
6.1 INTRODUCTION 142
6.2 CLINICAL CHEMISTRY 143
6.2.1 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE 145
6.2.1.1 Companion animals 145
6.2.1.1.1 Rising pet ownership and preventive health trends to drive segment growth 145
6.2.1.2 Livestock animals 147
6.2.1.2.1 Rising focus on herd health, food safety, and export compliance to strengthen segment growth 147
6.3 IMMUNODIAGNOSTICS 149
6.3.1 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE 152
6.3.1.1 ELISA 152
6.3.1.1.1 ELISA tests to dominate immunodiagnostics segment owing to widespread use in infectious disease detection 152
6.3.2 LATERAL FLOW ASSAYS 154
6.3.2.1 Technological advancements and cost-effectiveness to aid market growth 154
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 156
6.3.3.1 Rising prevalence of atopic disorders and adoption of precision allergy testing to augment market growth 156
6.3.4 OTHER IMMUNODIAGNOSTIC SERVICES 158
6.3.5 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE 160
6.3.5.1 Companion animals 160
6.3.5.1.1 High pet care spending and preventive diagnostics to propel market growth 160
6.3.5.2 Livestock animals 162
6.3.5.2.1 Regulatory compliance, food safety, and disease surveillance to sustain steady demand 162
6.4 MOLECULAR DIAGNOSTICS 164
6.4.1 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE 167
6.4.2 PCR TESTS 167
6.4.2.1 High sensitivity and diagnostic accuracy to drive dominance of PCR tests 167
6.4.3 MICROARRAYS 169
6.4.3.1 Advancements in genetic profiling and pharmacogenomics to expand microarray applications 169
6.4.4 NUCLEIC ACID SEQUENCING 171
6.4.4.1 Rising adoption of next-generation sequencing and precision genomics to fuel market growth 171
6.4.5 OTHER MOLECULAR DIAGNOSTIC SERVICES 173
6.4.6 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE 175
6.4.6.1 Companion animals 175
6.4.6.1.1 High pet-owner spending, precision diagnostics, and rapid turnaround to drive dominance 175
6.4.6.2 Livestock animals 177
6.4.6.2.1 Regulatory mandates, disease surveillance, and one health initiatives to strengthen market presence 177
6.5 HEMATOLOGY 179
6.5.1 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE 181
6.5.1.1 Companion animals 181
6.5.1.1.1 High diagnostic frequency and technological advancements TO sustain segment growth 181
6.5.1.2 Livestock animals 183
6.5.1.2.1 Rising focus on herd health, biosecurity, and productivity optimization to drive steady market growth 183
?
6.6 URINALYSIS 185
6.6.1 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY ANIMAL TYPE 187
6.6.1.1 Companion animals 187
6.6.1.1.1 Rising incidences of renal diseases in companion animals to drive market 187
6.6.1.2 Livestock animals 189
6.6.1.2.1 Growing emphasis on metabolic profiling and precision herd management to strengthen livestock urinalysis segment 189
6.7 HISTOPATHOLOGY & CYTOLOGY 191
6.7.1 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE 193
6.7.1.1 Companion animals 193
6.7.1.1.1 Clinical reliance on laboratory-based tissue and cellular diagnostics for definitive case management to drive market 193
6.7.1.2 Livestock animals 195
6.7.1.2.1 Biosecurity investments and disease surveillance programs to drive steady demand 195
6.8 MICROBIOLOGY 197
6.8.1 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE 199
6.8.1.1 Companion animals 199
6.8.1.1.1 Rising AMR awareness and shift toward rapid and automated testing to spur market growth 199
6.8.1.2 Livestock animals 201
6.8.1.2.1 Antimicrobial resistance monitoring and food safety compliance to sustain demand 201
6.9 OTHER SERVICES 203
6.9.1 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,
BY ANIMAL TYPE 205
6.9.1.1 Companion animals 205
6.9.1.2 Livestock animals 207
7 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION 209
7.1 INTRODUCTION 210
7.2 CLINICAL PATHOLOGY 210
7.2.1 INCREASING AWARENESS OF ANIMAL HEALTH TO DRIVE MARKET 210
7.3 BACTERIOLOGY 213
7.3.1 GROWTH IN VETERINARY HEALTHCARE EXPENDITURE TO DRIVE MARKET 213
7.4 VIROLOGY 215
7.4.1 EMERGING INFECTIOUS DISEASES IN ANIMALS TO PROPEL MARKET GROWTH 215
7.5 PARASITOLOGY 217
7.5.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO AUGMENT MARKET GROWTH 217
?
7.6 PRODUCTIVITY TESTING 219
7.6.1 EXPANSION OF LIVESTOCK INDUSTRIES TO SUPPORT MARKET GROWTH 219
7.7 PREGNANCY TESTING 221
7.7.1 ADVANCED BREEDING TECHNIQUES AND RESPONSIBLE PET
OWNERSHIP TO DRIVE MARKET GROWTH 221
7.8 TOXICOLOGY TESTING 223
7.8.1 GLOBALIZATION OF FOOD SUPPLY CHAINS TO PROPEL MARKET GROWTH 223
7.9 OTHER APPLICATIONS 225
8 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE 227
8.1 INTRODUCTION 228
8.2 COMPANION ANIMALS 228
8.2.1 DOGS 232
8.2.1.1 High insurance coverage and availability of reimbursements
to drive market 232
8.2.2 CATS 234
8.2.2.1 Increasing pet cat population to support market uptake 234
8.2.3 HORSES 236
8.2.3.1 Growing awareness regarding equine health to fuel market growth 236
8.2.4 OTHER COMPANION ANIMALS 239
8.3 LIVESTOCK ANIMALS 240
8.3.1 CATTLE 244
8.3.1.1 Growing consumption of dairy products to drive market growth 244
8.3.2 SWINE 246
8.3.2.1 Increasing incidence of infectious diseases to fuel market growth 246
8.3.3 POULTRY 248
8.3.3.1 Increasing demand for poultry meat to spur market growth 248
8.3.4 SHEEP & GOATS 250
8.3.4.1 International trade and strict health regulations to drive market 250
8.3.5 OTHER LIVESTOCK ANIMALS 252
9 VETERINARY REFERENCE LABORATORY MARKET, BY END USER 254
9.1 INTRODUCTION 255
9.2 VETERINARY HOSPITALS & CLINICS 255
9.2.1 RISING PET OWNERSHIP AND GROWING DIAGNOSTIC AWARENESS TO DRIVE DEMAND FOR VETERINARY REFERENCE LABS 255
9.3 POINT-OF-CARE/IN-HOUSE TESTING 258
9.3.1 INCREASING COLLABORATIONS BETWEEN IN-HOUSE DIAGNOSTIC SETUPS AND REFERENCE LABORATORIES TO AID MARKET GROWTH 258
9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 260
9.4.1 INCREASING ACADEMIC COLLABORATIONS AND FUNDING TO DRIVE UTILIZATION OF REFERENCE LABORATORY SERVICES 260
9.5 OTHER END USERS 262
10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION 264
10.1 INTRODUCTION 265
10.2 NORTH AMERICA 266
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 266
10.2.2 US 274
10.2.2.1 US to dominate Norths American veterinary reference laboratory market during forecast period 274
10.2.3 CANADA 281
10.2.3.1 Growing pet adoption, rising animal healthcare expenditure, and increasing number of veterinary practices to drive market 281
10.3 EUROPE 288
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 289
10.3.2 GERMANY 296
10.3.2.1 Increasing pet healthcare expenditure and rising demand for animal-derived food products to aid market growth 296
10.3.3 UK 303
10.3.3.1 Increased pet ownership and availability of animal health insurance policies to augment market growth 303
10.3.4 FRANCE 310
10.3.4.1 Growth of livestock industry and high companion animal population to support market growth 310
10.3.5 ITALY 317
10.3.5.1 Rising awareness about pet healthcare to drive market 317
10.3.6 SPAIN 324
10.3.6.1 Growing demand for pig and poultry products to drive market 324
10.3.7 NETHERLANDS 331
10.3.7.1 Increasing animal healthcare expenditure to drive market growth 331
10.3.8 REST OF EUROPE 338
10.4 ASIA PACIFIC 345
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 345
10.4.2 CHINA 353
10.4.2.1 Large pool of food-producing animals to drive market 353
10.4.3 JAPAN 360
10.4.3.1 Awareness about zoonotic diseases and increased pet expenditure to propel market growth 360
10.4.4 INDIA 368
10.4.4.1 Growing demand for livestock products and increasing awareness about animal health to support market growth 368
10.4.5 AUSTRALIA 376
10.4.5.1 Increasing investments in pet services and products to aid market growth 376
10.4.6 SOUTH KOREA 383
10.4.6.1 Increasing pet population in urban households to drive market 383
?
10.4.7 THAILAND 390
10.4.7.1 Rapidly expanding companion animal population to create higher demand for advanced diagnostic testing 390
10.4.8 NEW ZEALAND 397
10.4.8.1 Increased demand for preventive care and high aging pet population to drive market growth 397
10.4.9 REST OF ASIA PACIFIC 404
10.5 LATIN AMERICA 411
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 412
10.5.2 BRAZIL 419
10.5.2.1 Increasing use of reproductive technologies in livestock industry to propel market growth 419
10.5.3 MEXICO 426
10.5.3.1 Increasing adoption of advanced diagnostic technologies to propel market growth 426
10.5.4 ARGENTINA 433
10.5.4.1 Focus on advanced healthcare and regular disease monitoring among companion animals to drive market 433
10.5.5 REST OF LATIN AMERICA 440
10.6 MIDDLE EAST & AFRICA 447
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 448
10.6.2 GCC COUNTRIES 455
10.6.2.1 Kingdom of Saudi Arabia 462
10.6.2.1.1 Technology advancements in veterinary diagnostics to boost market growth 462
10.6.2.2 UAE 469
10.6.2.2.1 Government support and favorable initiatives to fuel market growth 469
10.6.2.3 Rest of GCC Countries 476
10.6.3 REST OF MIDDLE EAST & AFRICA 482
11 COMPETITIVE LANDSCAPE 490
11.1 INTRODUCTION 490
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 490
11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VETERINARY REFERENCE LABORATORY MARKET 490
11.3 REVENUE ANALYSIS, 2020?2024 493
11.4 MARKET SHARE ANALYSIS, 2024 494
11.4.1 RANKING OF KEY MARKET PLAYERS 494
11.4.2 GLOBAL MARKET SHARE ANALYSIS 495
11.4.3 US MARKET SHARE ANALYSIS 497
?
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 498
11.5.1 STARS 498
11.5.2 EMERGING LEADERS 498
11.5.3 PERVASIVE PLAYERS 498
11.5.4 PARTICIPANTS 498
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 500
11.5.5.1 Company footprint 500
11.5.5.2 Region footprint 501
11.5.5.3 Service footprint 502
11.5.5.4 Animal type footprint 503
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 504
11.6.1 PROGRESSIVE COMPANIES 504
11.6.2 RESPONSIVE COMPANIES 504
11.6.3 DYNAMIC COMPANIES 504
11.6.4 STARTING BLOCKS 504
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SME PLAYERS, 2024 506
11.6.5.1 Detailed list of key startups/SME players 506
11.6.5.2 Competitive benchmarking of key emerging players/startups 507
11.7 BRAND/PRODUCT COMPARISON 508
11.8 R&D EXPENDITURE OF KEY PLAYERS 509
11.9 COMPANY VALUATION & FINANCIAL METRICS 509
11.9.1 FINANCIAL METRICS 509
11.9.2 COMPANY VALUATION 510
11.10 COMPETITIVE SCENARIO 510
11.10.1 SERVICE LAUNCHES & ENHANCEMENTS 510
11.10.2 DEALS 512
11.10.3 EXPANSIONS 513
11.10.4 OTHER DEVELOPMENTS 514
12 COMPANY PROFILES 515
12.1 KEY PLAYERS 515
12.1.1 IDEXX LABORATORIES, INC. 515
12.1.1.1 Business overview 515
12.1.1.2 Services offered 517
12.1.1.3 Recent developments 520
12.1.1.3.1 Service launches and enhancements 520
12.1.1.4 MnM view 521
12.1.1.4.1 Key strengths 521
12.1.1.4.2 Strategic choices 522
12.1.1.4.3 Weaknesses & competitive threats 522
?
12.1.2 MARS, INCORPORATED 523
12.1.2.1 Business overview 523
12.1.2.2 Services offered 524
12.1.2.3 Recent developments 526
12.1.2.3.1 Service launches 526
12.1.2.3.2 Deals 526
12.1.2.3.3 Expansions 527
12.1.2.4 MnM view 527
12.1.2.4.1 Key strengths 527
12.1.2.4.2 Strategic choices 527
12.1.2.4.3 Weaknesses & competitive threats 528
12.1.3 ZOETIS SERVICES LLC 529
12.1.3.1 Business overview 529
12.1.3.2 Services offered 531
12.1.3.3 Recent developments 533
12.1.3.3.1 Deals 533
12.1.3.3.2 Expansions 534
12.1.3.4 MnM view 534
12.1.3.4.1 Key strengths 534
12.1.3.4.2 Strategic choices 535
12.1.3.4.3 Weaknesses & competitive threats 535
12.1.4 GD (ROYAL GD ANIMAL HEALTH) 536
12.1.4.1 Business overview 536
12.1.4.2 Services offered 537
12.1.4.3 Recent developments 543
12.1.4.3.1 Service launches 543
12.1.4.3.2 Deals 544
12.1.4.3.3 Expansions 545
12.1.4.4 MnM view 545
12.1.4.4.1 Key strengths 545
12.1.4.4.2 Strategic choices 546
12.1.4.4.3 Weaknesses & competitive threats 546
12.1.5 LABOKLIN GMBH & CO. KG 547
12.1.5.1 Business overview 547
12.1.5.2 Services offered 547
12.1.5.3 Recent developments 549
12.1.5.3.1 Service launches 549
12.1.5.4 MnM view 550
12.1.5.4.1 Key strengths 550
12.1.5.4.2 Strategic choices 550
12.1.5.4.3 Weaknesses & competitive threats 550
?
12.1.6 CVS (UK) LIMITED 551
12.1.6.1 Business overview 551
12.1.6.2 Services offered 553
12.1.6.3 Recent developments 556
12.1.6.3.1 Service launches 556
12.1.7 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS 557
12.1.7.1 Business overview 557
12.1.7.2 Services offered 557
12.1.8 ANIMAL AND PLANT HEALTH AGENCY 559
12.1.8.1 Business overview 559
12.1.8.2 Services offered 559
12.1.8.3 Recent developments 561
12.1.8.3.1 Other developments 561
12.1.9 ICAR?NIVEDI (NATIONAL INSTITUTE OF VETERINARY EPIDEMIOLOGY AND DISEASE INFORMATICS) 562
12.1.9.1 Business overview 562
12.1.9.2 Services offered 562
12.1.10 NATIONAL VETERINARY SERVICES 564
12.1.10.1 Business overview 564
12.1.10.2 Services offered 565
12.1.10.3 Recent developments 566
12.1.10.3.1 Expansions 566
12.1.10.3.2 Other developments 567
12.1.11 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY (TVMDL) 568
12.1.11.1 Business overview 568
12.1.11.2 Services offered 568
12.1.11.3 Recent developments 569
12.1.11.3.1 Service launches and enhancements 569
12.1.12 ANIMAL HEALTH DIAGNOSTIC CENTER, CORNELL UNIVERSITY 571
12.1.12.1 Business overview 571
12.1.12.2 Services offered 571
12.1.12.3 Recent developments 573
12.1.12.3.1 Service launches 573
12.1.12.3.2 Expansions 574
12.1.13 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY) 575
12.1.13.1 Business overview 575
12.1.13.2 Services offered 575
12.1.14 BIOBEST LABORATORIES LTD. 578
12.1.14.1 Business overview 578
12.1.14.2 Services offered 579
12.1.14.3 Recent developments 581
12.1.14.3.1 Expansions 581
12.1.15 PRIVATE VETERINARY CLINIC SAN MARCO SRL UNIPERSONALE 582
12.1.15.1 Business overview 582
12.1.15.2 Services offered 582
12.2 OTHER PLAYERS 584
12.2.1 ROYAL VETERINARY COLLEGE, UNIVERSITY OF LONDON 584
12.2.2 UNIVERSITY OF GUELPH, ANIMAL HEALTH LABORATORY 585
12.2.3 VAXXINOVA 586
12.2.4 MIRA VISTA LABS 588
12.2.5 ELLIE DIAGNOSTICS 589
12.2.6 PROTATEK INTERNATIONAL, INC. 590
12.2.7 THE PIRBRIGHT INSTITUTE 591
12.2.8 CVR LABORATORY (CVRL) 592
12.2.9 VETERINARY PATHOLOGY GROUP 593
12.2.10 FRIEDRICH-LOEFFLER-INSTITUT (FLI) 594
13 APPENDIX 595
13.1 DISCUSSION GUIDE 595
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 601
13.3 CUSTOMIZATION OPTIONS 603
13.3.1 SERVICE ANALYSIS 603
13.3.2 COMPANY INFORMATION 603
13.3.3 GEOGRAPHIC ANALYSIS 603
13.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 603
13.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT 603
13.3.6 BY SERVICE MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 603
13.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 603
13.4 RELATED REPORTS 604
13.5 AUTHOR DETAILS 605

ページTOPに戻る

List of Tables/Graphs

＜P＞TABLE 1 VETERINARY REFERENCE LABORATORY MARKET: INCLUSIONS & EXCLUSIONS 50
TABLE 2 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 51
TABLE 3 VETERINARY REFERENCE LABORATORY MARKET: MARKET ASSUMPTIONS 70
TABLE 4 VETERINARY REFERENCE LABORATORY MARKET: RISK ANALYSIS 71
TABLE 5 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES, 2009?2023 86
TABLE 6 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2024,
BY ANIMAL TYPE (MILLIONS) 88
TABLE 7 US: AVERAGE PREMIUMS PAID, 2020 VS. 2023 90
TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012?2023 (USD MILLION) 91
TABLE 9 VETERINARY REFERENCE LABORATORY MARKET: PORTER’S FIVE FORCES 102
TABLE 10 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY REFERENCE LABORATORY PRODUCTS (%) 105
TABLE 11 KEY BUYING CRITERIA FOR TOP THREE END USERS 107
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 108
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 15 MAJOR PATENTS IN VETERINARY REFERENCE LABORATORY MARKET 113
TABLE 16 AVERAGE SELLING PRICE TREND OF VETERINARY REFERENCE LABORATORY SERVICES, BY KEY PLAYER, 2022?2024 (USD) 115
TABLE 17 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY SERVICES, BY REGION, 2022?2024 (USD) 117
TABLE 18 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTIC SERVICES, BY REGION, 2022?2024 (USD) 118
TABLE 19 AVERAGE SELLING PRICE TREND OF MOLECULAR DIAGNOSTIC SERVICES,
BY REGION, 2022?2024 (USD) 118
TABLE 20 AVERAGE SELLING PRICE TREND OF HAEMATOLOGY SERVICES, BY REGION, 2022?2024 (USD) 118
TABLE 21 AVERAGE SELLING PRICE TREND OF HISTOPATHOLOGY &CYTOLOGY SERVICES,
BY REGION, 2022?2024 (USD) 119
TABLE 22 AVERAGE SELLING PRICE TREND OF URINALYSIS SERVICES, BY REGION,
2022?2024 (USD) 119
TABLE 23 KEY CONFERENCES & EVENTS IN VETERINARY REFERENCE LABORATORY MARKET, JANUARY 2025?DECEMBER 2026 122
TABLE 24 KEY COMPANIES IMPLEMENTING AI IN VETERINARY REFERENCE
LABORATORY MARKET 126
TABLE 25 VETERINARY REFERENCE LABORATORY PROVIDERS: ROLE IN ECOSYSTEM 127
TABLE 26 CASE STUDY 1: DIGITAL CYTOLOGY WORKFLOW ACCELERATION TO ENHANCE DIAGNOSTIC TURNAROUND IN VETERINARY PRACTICES 131
TABLE 27 CASE STUDY 2: IDEXX-CANCERDX (LYMPHOMA DIAGNOSTIC SERVICE) TO ADVANCE ONCOLOGY DETECTION THROUGH BLOOD-BASED TESTING 132
TABLE 28 CASE STUDY 3: VIRTUAL LABORATORY INTEGRATION TO ENHANCE CYTOLOGY TURNAROUND AND CLINICAL WORKFLOW 133
TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES 136
TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE VETERINARY REFERENCE LABORATORY 136
TABLE 31 IMPACT OF US TARIFF ON CANADA 138
TABLE 32 IMPACT OF US TARIFF ON GERMANY AND UK 138
TABLE 33 IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 139
TABLE 34 IMPACT OF US TARIFF ON MEXICO 139
TABLE 35 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 142
TABLE 36 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY SERVICES 143
TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,
BY COUNTRY, 2023?2030 (USD MILLION) 144
TABLE 38 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 145
TABLE 39 CLINICAL CHEMISTRY MARKET FOR COMPANION ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 146
TABLE 40 CLINICAL CHEMISTRY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 148
TABLE 41 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES 150
TABLE 42 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,
BY COUNTRY, 2023?2030 (USD MILLION) 151
TABLE 43 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,
BY SERVICE, 2023?2030 (USD MILLION) 152
TABLE 44 IMMUNODIAGNOSTICS MARKET FOR ELISA, BY COUNTRY,
2023?2030 (USD MILLION) 153
TABLE 45 IMMUNODIAGNOSTICS MARKET FOR LATERAL FLOW ASSAYS,
BY COUNTRY, 2023?2030 (USD MILLION) 155
TABLE 46 IMMUNODIAGNOSTICS MARKET FOR ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2023?2030 (USD MILLION) 157
TABLE 47 OTHER IMMUNODIAGNOSTICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 159
TABLE 48 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS,
BY ANIMAL TYPE , 2023?2030 (USD MILLION) 160
TABLE 49 IMMUNODIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 161
TABLE 50 IMMUNODIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 163
TABLE 51 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTIC SERVICES 165
TABLE 52 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023?2030 (USD MILLION) 166
TABLE 53 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 167
TABLE 54 MOLECULAR DIAGNOSTICS MARKET FOR PCR TESTS, BY COUNTRY,
2023?2030 (USD MILLION) 168
TABLE 55 MOLECULAR DIAGNOSTICS MARKET FOR MICROARRAYS, BY COUNTRY,
2023?2030 (USD MILLION) 170
TABLE 56 MOLECULAR DIAGNOSTICS MARKET FOR NUCLEIC ACID SEQUENCING,
BY COUNTRY, 2023?2030 (USD MILLION) 172
TABLE 57 OTHER MOLECULAR DIAGNOSTIC SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 174
TABLE 58 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 175
TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023?2030 (USD MILLION) 176
TABLE 60 MOLECULAR DIAGNOSTICS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023?2030 (USD MILLION) 178
TABLE 61 KEY PLAYERS PROVIDING HAEMATOLOGY SERVICES 179
TABLE 62 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY COUNTRY, 2023?2030 (USD MILLION) 180
TABLE 63 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 181
TABLE 64 HAEMATOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 182
TABLE 65 HAEMATOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 184
TABLE 66 KEY PLAYERS PROVIDING URINALYSIS TECHNOLOGIES 185
TABLE 67 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY COUNTRY, 2023?2030 (USD MILLION) 186
TABLE 68 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 187
TABLE 69 URINALYSIS MARKET FOR COMPANION ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 188
TABLE 70 URINALYSIS MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 190
TABLE 71 KEY PLAYERS PROVIDING HISTOPATHOLOGY & CYTOLOGY SERVICES 191
TABLE 72 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY COUNTRY, 2023?2030 (USD MILLION) 192
TABLE 73 VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 193
TABLE 74 HISTOPATHOLOGY & CYTOLOGY MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2023?2030 (USD MILLION) 194
TABLE 75 HISTOPATHOLOGY & CYTOLOGY MARKET FOR LIVESTOCK ANIMALS,
BY COUNTRY, 2023?2030 (USD MILLION) 196
TABLE 76 KEY PLAYERS PROVIDING MICROBIOLOGY SERVICES 197
TABLE 77 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY COUNTRY, 2023?2030 (USD MILLION) 198
TABLE 78 VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 199
TABLE 79 MICROBIOLOGY MARKET FOR COMPANION ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 200
TABLE 80 MICROBIOLOGY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY,
2023?2030 (USD MILLION) 202
TABLE 81 KEY PLAYERS PROVIDING OTHER VETERINARY REFERENCE
LABORATORY SERVICES 203
TABLE 82 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,
BY COUNTRY, 2023?2030 (USD MILLION) 204
TABLE 83 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 205
TABLE 84 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2023?2030 (USD MILLION) 206
TABLE 85 OTHER VETERINARY REFERENCE LABORATORY SERVICES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2023?2030 (USD MILLION) 208
TABLE 86 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 210
TABLE 87 KEY PLAYERS PROVIDING CLINICAL PATHOLOGY SERVICES 211
TABLE 88 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY,
BY COUNTRY, 2023?2030 (USD MILLION) 212
TABLE 89 KEY PLAYERS PROVIDING BACTERIOLOGY SERVICES 213
TABLE 90 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY,
BY COUNTRY, 2023?2030 (USD MILLION) 214
TABLE 91 KEY PLAYERS PROVIDING VIROLOGY SERVICES 215
TABLE 92 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY, BY COUNTRY, 2023?2030 (USD MILLION) 216
TABLE 93 KEY PLAYERS PROVIDING PARASITOLOGY SERVICES 217
TABLE 94 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY,
BY COUNTRY, 2023?2030 (USD MILLION) 218
TABLE 95 KEY PLAYERS PROVIDING PRODUCTIVITY TESTING SERVICES 219
TABLE 96 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING,
BY COUNTRY, 2023?2030 (USD MILLION) 220
TABLE 97 KEY PLAYERS PROVIDING PREGNANCY TESTING SERVICES 221
TABLE 98 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING,
BY COUNTRY, 2023?2030 (USD MILLION) 222
TABLE 99 KEY PLAYERS PROVIDING TOXICOLOGY TESTING SERVICES 223
TABLE 100 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY TESTING,
BY COUNTRY, 2023?2030 (USD MILLION) 224
TABLE 101 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 226
TABLE 102 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2023?2030 (USD MILLION) 228
TABLE 103 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR COMPANION ANIMALS 229
TABLE 104 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,
BY TYPE, 2023?2030 (USD MILLION) 230
TABLE 105 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2023?2030 (USD MILLION) 231
TABLE 106 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY
SERVICES FOR DOGS 232
TABLE 107 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY,
2023?2030 (USD MILLION) 233
TABLE 108 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES
FOR CATS 234
TABLE 109 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY,
2023?2030 (USD MILLION) 235
TABLE 110 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY
SERVICES FOR HORSES 236
TABLE 111 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2023?2030 (USD MILLION) 238
TABLE 112 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2023?2030 (USD MILLION) 239
TABLE 113 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES FOR LIVESTOCK ANIMALS 240
TABLE 114 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,
BY TYPE, 2023?2030 (USD MILLION) 242
TABLE 115 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,
BY COUNTRY, 2023?2030 (USD MILLION) 243
TABLE 116 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES
FOR CATTLE 244
TABLE 117 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2023?2030 (USD MILLION) 245
TABLE 118 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES
FOR SWINE 246
TABLE 119 VETERINARY REFERENCE LABORATORY MARKET FOR SWINE, BY COUNTRY,
2023?2030 (USD MILLION) 247
TABLE 120 KEY PLAYERS PROVIDING VETERINARY REFERENCE LABORATORY SERVICES
FOR POULTRY 248
TABLE 121 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2023?2030 (USD MILLION) 249
TABLE 122 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP & GOATS,
BY COUNTRY, 2023?2030 (USD MILLION) 251
TABLE 123 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2023?2030 (USD MILLION) 253
TABLE 124 VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 255
TABLE 125 US: BASIC ANNUAL EXPENSES FOR CATS AND DOGS, 2023 (USD) 256
TABLE 126 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY HOSPITALS & CLINICS BY COUNTRY, 2023?2030 (USD MILLION) 257
TABLE 127 VETERINARY REFERENCE LABORATORY MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING BY COUNTRY, 2023?2030 (USD MILLION) 259
TABLE 128 VETERINARY REFERENCE LABORATORY MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2023?2030 (USD MILLION) 261
TABLE 129 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 263
TABLE 130 VETERINARY REFERENCE LABORATORY MARKET, BY REGION,
2023?2030 (USD MILLION) 266
TABLE 131 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 268
TABLE 132 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023?2030 (USD MILLION) 268
TABLE 133 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 269
TABLE 134 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 269
TABLE 135 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 269
TABLE 136 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 270
TABLE 137 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 270
TABLE 138 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 270
TABLE 139 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 271
TABLE 140 NORTH AMERICA: OTHER VETERINARY REFERENCE LABORATORY MARKET,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 271
TABLE 141 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 271
TABLE 142 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 272
TABLE 143 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY APPLICATION, 2023?2030 (USD MILLION) 272
TABLE 144 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 273
TABLE 145 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 273
TABLE 146 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 273
TABLE 147 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY END USER, 2023?2030 (USD MILLION) 274
TABLE 148 US: KEY MACROINDICATORS 275
TABLE 149 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 275
TABLE 150 US: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 276
TABLE 151 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 276
TABLE 152 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 276
TABLE 153 US: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 277
TABLE 154 US: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 277
TABLE 155 US: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 277
TABLE 156 US: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 278
TABLE 157 US: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 278
TABLE 158 US: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 278
TABLE 159 US: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 279
TABLE 160 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 279
TABLE 161 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2023?2030 (USD MILLION) 280
TABLE 162 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 280
TABLE 163 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,
BY TYPE, 2023?2030 (USD MILLION) 280
TABLE 164 US: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 281
TABLE 165 CANADA: KEY MACROINDICATORS 282
TABLE 166 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 282
TABLE 167 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 283
TABLE 168 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 283
TABLE 169 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 283
TABLE 170 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 284
TABLE 171 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 284
TABLE 172 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 284
TABLE 173 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 285
TABLE 174 CANADA: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 285
TABLE 175 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 285
TABLE 176 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 286
TABLE 177 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 286
TABLE 178 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 287
TABLE 179 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 287
TABLE 180 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 287
TABLE 181 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 288
TABLE 182 EUROPE: COMPANION POPULATION, BY COUNTRY, 2023 (MILLION) 289
TABLE 183 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 290
TABLE 184 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 290
TABLE 185 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 291
TABLE 186 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 291
TABLE 187 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 291
TABLE 188 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 292
TABLE 189 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 292
TABLE 190 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 292
TABLE 191 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 293
TABLE 192 EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 293
TABLE 193 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 293
TABLE 194 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 294
TABLE 195 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 294
TABLE 196 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 295
TABLE 197 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 295
TABLE 198 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 295
TABLE 199 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 296
TABLE 200 GERMANY: KEY MACROINDICATORS 297
TABLE 201 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 297
TABLE 202 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 297
TABLE 203 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 298
TABLE 204 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 298
TABLE 205 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 298
TABLE 206 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 299
TABLE 207 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 299
TABLE 208 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 299
TABLE 209 GERMANY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 300
TABLE 210 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 300
TABLE 211 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 300
TABLE 212 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 301
TABLE 213 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 301
TABLE 214 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 302
TABLE 215 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 302
TABLE 216 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 303
TABLE 217 UK: KEY MACROINDICATORS 304
TABLE 218 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 304
TABLE 219 UK: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 305
TABLE 220 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 305
TABLE 221 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 305
TABLE 222 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 306
TABLE 223 UK: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 306
TABLE 224 UK: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 306
TABLE 225 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 307
TABLE 226 UK: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 307
TABLE 227 UK: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 307
TABLE 228 UK: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 308
TABLE 229 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 308
TABLE 230 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2023?2030 (USD MILLION) 309
TABLE 231 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 309
TABLE 232 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS,
BY TYPE, 2023?2030 (USD MILLION) 309
TABLE 233 UK: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 310
TABLE 234 FRANCE: KEY MACROINDICATORS 310
TABLE 235 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 311
TABLE 236 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 311
TABLE 237 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 312
TABLE 238 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 312
TABLE 239 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 312
TABLE 240 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 313
TABLE 241 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 313
TABLE 242 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 313
TABLE 243 RANCE: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 314
TABLE 244 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 314
TABLE 245 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 314
TABLE 246 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 315
TABLE 247 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 315
TABLE 248 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 316
TABLE 249 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 316
TABLE 250 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 317
TABLE 251 ITALY: KEY MACROINDICATORS 317
TABLE 252 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 318
TABLE 253 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 318
TABLE 254 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 319
TABLE 255 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 319
TABLE 256 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 319
TABLE 257 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 320
TABLE 258 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 320
TABLE 259 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 320
TABLE 260 ITALY: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 321
TABLE 261 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 321
TABLE 262 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 321
TABLE 263 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 322
TABLE 264 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2023?2030 (USD MILLION) 322
TABLE 265 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 323
TABLE 266 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 323
TABLE 267 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 324
TABLE 268 SPAIN: KEY MACROINDICATORS 325
TABLE 269 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE,
2023?2030 (USD MILLION) 325
TABLE 270 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 326
TABLE 271 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 326
TABLE 272 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 326
TABLE 273 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 327
TABLE 274 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 327
TABLE 275 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 327
TABLE 276 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 328
TABLE 277 SPAIN: OTHER VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 328
TABLE 278 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 328
TABLE 279 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 329
TABLE 280 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 329
TABLE 281 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2023?2030 (USD MILLION) 330
TABLE 282 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 330
TABLE 283 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 330
TABLE 284 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY END USER,
2023?2030 (USD MILLION) 331TABLE 285 NETHERLANDS: KEY MACROINDICATORS 331
TABLE 286 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023?2030 (USD MILLION) 332
TABLE 287 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 332
TABLE 288 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 333
TABLE 289 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 333
TABLE 290 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 333
TABLE 291 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 334
TABLE 292 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 334
TABLE 293 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 334
TABLE 294 NETHERLANDS: OTHER VETERINARY REFERENCE LABORATORY MARKET,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 335
TABLE 295 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 335
TABLE 296 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 335
TABLE 297 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 336
TABLE 298 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 336
TABLE 299 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 337
TABLE 300 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2023?2030 (USD MILLION) 337
TABLE 301 NETHERLANDS: VETERINARY REFERENCE LABORATORY MARKET, BY END USER, 2023?2030 (USD MILLION) 338
TABLE 302 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE, 2023?2030 (USD MILLION) 339
TABLE 303 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 339
TABLE 304 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 340
TABLE 305 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 340
TABLE 306 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 340
TABLE 307 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 341
TABLE 308 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR HISTOPATHOLOGY & CYTOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 341
TABLE 309 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR MICROBIOLOGY, BY ANIMAL TYPE, 2023?2030 (USD MILLION) 341
TABLE 310 REST OF EUROPE: OTHER VETERINARY REFERENCE LABORATORY MARKET,
BY ANIMAL TYPE, 2023?2030 (USD MILLION) 342
TABLE 311 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET
FOR IMMUNODIAGNOSTICS, BY SERVICE, 2023?2030 (USD MILLION) 342
TABLE 312 REST OF EUROPE: VETERINARY REFERENCE LABORATORY MARKET
FOR MOLECULAR DIAG